Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders

ABSTRACT Background: Azathioprine is a common first-line therapy for neuromyelitis optica spectrum disorder (NMOSD). Objective: The aim of this study was to determine whether long-term treatment (>10 years) with azathioprine is safe in NMOSD. Methods: We conducted a retrospective medical reco...

Full description

Bibliographic Details
Published in:Arquivos de Neuro-Psiquiatria
Main Authors: Ana Beatriz Ayroza Galvão Ribeiro GOMES, Milena Sales PITOMBEIRA, Douglas Kazutoshi SATO, Dagoberto CALLEGARO, Samira Luisa APÓSTOLOS-PEREIRA
Format: Article
Language:English
Published: Thieme Revinter Publicações 2021-03-01
Subjects:
Azathioprine
Neuromyelitis Optica
Therapeutics
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en

Similar Items